Bicycle Therapeutics PLC (BCYC)

14.68 -0.32 (-2.13%) USD  |  NASDAQ  |  Dec 20, 16:00
14.68 0.00 (0.00%) After-Hours: 20:00
More

Bicycle Therapeutics Max Drawdown (5Y): 78.82% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for BCYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Autolus Therapeutics PLC 96.58%
Mereo BioPharma Group PLC 94.92%
TC BioPharm (Holdings) PLC --
Adaptimmune Therapeutics PLC 96.45%
NuCana PLC 99.46%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) 4.550
Beta (5Y) 0.8580
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 64.70%
Historical Sharpe Ratio (5Y) 0.2474
Historical Sortino (5Y) 0.4427
Monthly Value at Risk (VaR) 5% (5Y Lookback) 25.25%